Michael Francis

Dr. Michael Francis


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in Organogenesis
Verified
Journal Article
Closed access
MFMichael Francis
Michael Francis
PSPatrick Sachs
Patrick Sachs
LELynne W. Elmore
Lynne W. Elmore
SHShawn E. Holt
Shawn E. Holt
Isolation of adipose-derived stem cells (ASCs) typically involves 8+ hours of intense effort, requiring specialized equipment and reagents. Here, we present an improved technique for isolating viab...

25 September 2008 in Biomedical Materials
Verified
Journal Article
Closed access
Scott SellScott Sell
Scott Sell
MFMichael Francis
Michael Francis
KGKoyal Garg
Koyal Garg
Michael McclureMichael Mcclure
Michael Mcclure
DSDavid G Simpson
David G Simpson
GBGary L Bowlin
Gary L Bowlin
The purpose of this study was to enhance the mechanical properties and slow the degradation of an electrospun fibrinogen scaffold, while maintaining the scaffold's high level of bioactivity. Three different cross-linkers were used to achieve this goal: glutaraldehyde vapour, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) in ethanol and genipin in ethanol. Scaffolds with a fibrinogen concentration of 120 mg ml(-1) were electrospun and cross-linked with one of the aforementioned cross-linkers. Mechanical properties were determined through uniaxial tensile testing performed on scaffolds incubated under standard culture conditions for 1 day, 7 days and 14 days. Cross-linked scaffolds were seeded with human foreskin fibroblasts (BJ-GFP-hTERT) and cultured for 7, 14 and 21 days, with histology and scanning electron microscopy performed upon completion of the time course. Mechanical testing revealed significantly increased peak stress and modulus values for the EDC and genipin cross-linked scaffolds, with significantly slowed degradation. However, cross-linking with EDC and genipin was shown to have some negative effect on the bioactivity of the scaffolds as cell migration throughout the thickness of the scaffold was slowed.

1 April 2017 in Acta Biomaterialia
Verified
Journal Article
Closed access
MFMichael Francis
Michael Francis
EBErick Breathwaite
Erick Breathwaite
ABAnna Bulysheva
Anna Bulysheva
FVFrency Varghese
Frency Varghese
RRRudy U. Rodriguez
Rudy U. Rodriguez
CZChristian Zemlin
Christian Zemlin

25 May 2012 in Cell and tissue research
Verified
Journal Article
Closed access
PDF file
PSPatrick Sachs
Patrick Sachs
MFMichael Francis
Michael Francis
MZMin Zhao
Min Zhao
JBJenni Brumelle
Jenni Brumelle
RRRaj R. Rao
Raj R. Rao
SHShawn E. Holt
Shawn E. Holt

1 July 2012 in Cancer Biology & Therapy
Verified
Journal Article
Open access
PDF file
MZMin Zhao
Min Zhao
PSPatrick Sachs
Patrick Sachs
XWXu Wang
Xu Wang
CDCatherine I. Dumur
Catherine I. Dumur
MIMichael O. Idowu
Michael O. Idowu
LELynne W. Elmore
Lynne W. Elmore
Data are accumulating to support a role for adipose-derived mesenchymal stem cells (MSCs) in breast cancer progression; however, to date most studies have relied on adipose MSCs from non-breast sources. There is a particular need to investigate the role of adipose MSCs in the pathogenesis of basal-like breast cancer, which develops at a disproportionate rate in pre-menopausal African-American women with a gain in adiposity. The aim of this study was to better understand how breast adipose MSCs (bMSCs) contribute to the progression of basal-like breast cancers by relying on isogenic HMT-3255 S3 (pre-invasive) and T4-2 (invasive) human cells that upon transplantation into nude mice resemble this tumor subtype. In vitro results suggested that bMSCs may contribute to breast cancer progression in multiple ways. bMSCs readily penetrate extracellular matrix components in part through their expression of matrix metalloproteinases 1 and 3, promote the invasion of T4-2 cells and efficiently chemoattract endothelial cells via a bFGF-independent, VEGF-A-dependent manner. As mixed xenografts, bMSCs stimulated the growth, invasion and desmoplasia of T4-2 tumors, yet these resident stem cells showed no observable effect on the progression of pre-invasive S3 cells. While bMSCs form vessel-like structures within Matrigel both in vitro and in vivo and chemoattract endothelial cells, there appeared to be no difference between T4-2/bMSC mixed xenografts and T4-2 xenografts with regard to intra- or peri-tumoral vascularity. Collectively, our data suggest that bMSCs may contribute to the progression of basal-like breast cancers by stimulating growth and invasion but not vasculogenesis or angiogenesis.

23 March 2012 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
MFMichael Francis
Michael Francis
PSPatrick Sachs
Patrick Sachs
PMParthasarathy A. Madurantakam
Parthasarathy A. Madurantakam
Scott SellScott Sell
Scott Sell
LELynne W. Elmore
Lynne W. Elmore
SHShawn E. Holt
Shawn E. Holt